Life Sciences

collaborative

Image - Eyeball with laser grid
Straight Talk® is good business
Image of Test Tubes

since 1902

focused

experienced

Life Sciences

Life science companies exist on the cutting edge of innovative technology and creative research, but history shows that achievement in the laboratory does not guarantee commercial success. The risks and challenges of development facing these companies are huge, but so are the potential rewards. For over 20 years, our attorneys have helped clients realize those rewards. As advisors to leaders in life sciences, pharmaceutical and medical device fields, our firm counsels startups and spin-offs in connection with:

Typical of our counsel are the following:

The resources we provide clients include: 

Counsel to Life Sciences Clients

We advise and guide biotechnology and life sciences clients from incorporation through exit strategies and beyond, assisting them as they take new ideas through the challenges of product development, patent approval and regulatory endorsement. 

Critical legal issues facing entrepreneurs in this industry often extend beyond securities law and patents. Our services include strategic counsel on the details of corporate structure, employment contracts, licensing agreements, distribution and supply agreements, and agreements with CROs and other subcontractors.

When transitioning to a public company becomes advantageous, or other capital needs beckon, our attorneys bring a wealth of experience to the table. 

We have helped clients raise billions of dollars through IPOs, subsequent public offerings and private placements and corporate strategic alliances.

Using our skills as business advisors, and contacts strengthened by our Equity and Debt Capital Markets practice group, we provide counsel to clients when obtaining capital, identifying growth opportunities and consolidating market share. In addition, we guide clients in:

Our Experience

The following is a list of representative transactions that our firm has completed for biotechnology and life science clients. Since 2006, we have represented clients in bids to acquire assets from Merck, Bristol-Myers Squibb Company and Roche Pharmaceuticals (each of these transactions was a buy-side transaction). We have also represented biotechnology and life science clients in negotiating supply agreements, distribution agreements, testing agreements and pharmacovigilence and drug safety agreements with major life science companies.

Our representation of biotechnology and life science clients has involved the acquisition of assets in 168 countries. Our mergers and acquisitions practice has involved the representation of buyers and sellers in transactions with an aggregate value of more than $206 billion in over 600 business combinations since 2010. Our corporate finance practice in the life science space has completed transactions valued at approximately $1 billion during this period.

Research Institutions—From Lab to Market

A significant area of our experience includes counsel for developing and exploiting business opportunities for venture capitalists and entrepreneurs involving university research institutions and startup technologies. 

We provided the legal counsel for the venture-backed technology transfer out of Baylor College of Medicine in 1984 and the technology licensing agreement funded by venture capitalists out of M.D. Anderson Cancer Center in 1985. We have formed several first-time life science venture funds and we continue to expand our counsel in this area.  

Our experience includes a wide range of deals in which we assisted clients in:

Finally, we work closely with our Intellectual Property practice group and devote substantial concern to securing and defending clients’ patent rights and navigating complex licensing issues.

Medical Device Manufacturing

For clients involved with medical device development, the firm maintains a strong Health Care practice group to guide clients through the maze of regulatory issues and approvals that define the industry. We also defend product liability lawsuits involving pharmaceuticals and medical devices. 

Related Practices

Related Industries

Firm Rankings

View All »

News

Events

Insights

View All »